Beta Thalassemia

Beta Thalassemia

Prevalence

People whose hemoglobin does not produce enough beta protein have beta thalassemia. It is found in people of Mediterranean descent, such as Italians and Greeks, and is also found in the Arabian Peninsula, Iran, Africa, Southeast Asia and southern China and India & Pakistan.

Type of Beta Thalassemia

  • Thalassemia Minor or Thalassemia Trait
  • Thalassemia Intermedia
  • Thalassemia major

Thalassemia Minor or Thalassemia Trait

In this condition, the lack of beta protein is not great enough to cause problems in the normal functioning of the hemoglobin. A person with this condition simply carries the genetic trait for thalassemia and will usually experience no health problems other than a possible mild anemia.

Thalassemia Intermedia

Thalassemia Intermedia has an extra ordinary wide clinical spectrum which includes mild and sever end. In case of mild end the person is asymptomatic until adult life ,while in case of sever end there is an early presentation between 2-6 years and that is why there is a borderline between thalassemia intermedia and the most severe form, thalassemia major, which can be confusing. Three main factors are responsible for clinical sequel of Thalassemia intermedia.

  • Ineffective erythropoiesis
  • Chronic Anemia
  • Iron Overload

Thalassemia Major or Cooley ’s anemia

This is the most severe form of beta thalassemia in which the complete lack of beta protein in the hemoglobin causes a life-threatening anemia that requires regular blood transfusions and extensive ongoing medical care. These extensive, lifelong blood transfusions lead to iron-overload which must be treated with chelation therapy to prevent early death from organ failure.

Clinical Diagnosis

Beta Thalassemia Major

  • Age 4 – 6 months or a child younger than 2 years of age .
  • Anemia
  • Hepatosplenomegaly
  • Jaundice
  • Thalassaemia Facies
  • Growth failure & retardation

Beta Thalassemia Intermedia

  • Milder Anemia
  • Extensive Thalassemia Facies
  • Hepatosplenomegaly

Alpha Thalassemia Treatment

  • Preventive & supportive
  • Folic acid supplements if evidence of hemolysis.
  • Avoid oxidative compounds medications.
  • Avoid iron therapy unless iron deficiency documented and periodic monitoring of iron overload.
  • Prompt treatment of infections.
  • Splenomegaly: If marked splenomegaly consider pre splenectomy work up & splenectomy.
  • Special attention for pregnant women with HbH.
  • Risk of fetal neural tube defect. Folic acid supplements during periconceptual period and beyond.
  • Iron supplements if iron deficient
how can we help you?

Contact us at the AMTF office or submit a Inquiry form online.

#AMTF Blood Donation Camp at Amreli Steels (Dhabeji Unit)
April 24, 2019
... See MoreSee Less

View on Facebook

Ms. Fariya Zameen (Head of Marketing) & Mr. Muhammad Azam (Head Services Marketing) from Faysal Bank visited #AMTF
April 24, 2019
... See MoreSee Less

View on Facebook

#AMTF Thalassemia Awareness Session at Amreli Steels - Dhabeji Unit
April 23, 2019
... See MoreSee Less

View on Facebook

Ehsas Karo, Kuch Khas Karo!

DONATE ONLINE:
bit.ly/2PuKRGs
... See MoreSee Less

View on Facebook

#AMTF Blood Donation Camp at Greenwich University, Karachi
April 16, 2019
... See MoreSee Less

View on Facebook

#AMTF Blood Donation Camp at PAF-KIET, Nazimabad Campus
April 15, 2019
... See MoreSee Less

View on Facebook

#AMTF Blood Donation Camp at Institute of Business Management (IoBM)
April 9, 2019
... See MoreSee Less

View on Facebook

Dr. Asim Qidwai, Founder & CEO AMTF had a meeting with High Commissioner Pakistan at Canada Mr. Raza Bashir Tarar in Ottawa
April 4, 2019PRESS RELEASE
April 04, 2019
Dr. Asim Qidwai, Founder & C.E.O of Afzaal Memorial Thalassemia Foundation (AMTF) called on the High Commissioner of Pakistan, Raza Bashir Tarar and briefed him on the work of the Foundation in the field of health care related to children from blood disorder.
The High Commissioner appreciated the plan of the Foundation for conducting awareness sessions with the Pakistani community living abroad. He agreed with the vision of the foundation to deliver the utmost level of passionate care to the patients of thalassemia. The High Commissioner urged the founder for developing synergy among the institutes working in Pakistan on the childhood blood diseases.
Dr. Asim Qidwai also informed the High Commissioner for his drive to include thalassemia awareness and prevention in the curriculum of high schools and colleges of Pakistan.
*****
... See MoreSee Less

View on Facebook

for donations click here